Advertisement

Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation

      ABSTRACT

      Objectives

      Premature ejaculation (PE) is the most common ejaculatory dysfunction. We assessed the efficacy of sildenafil to increase the time to ejaculation, improve ejaculatory control, and decrease the postejaculatory erectile refractory time in men with PE.

      Design and Methods

      The main study was an 8‐week, double‐blind, placebo‐controlled, parallel group study in men between 18 and 65 years of age with diagnosed PE. A substudy was also conducted using a subset of patients (two‐way crossover, one center) before entry to the main study. The primary study measured intravaginal ejaculatory latency (IELT) and responses to the Index of Premature Ejaculation (IPE) questionnaire. The substudy measured vibrotactile stimulation ejaculatory latency time (VTS‐ELT) and postejaculatory erectile refractory time. Differences between treatment groups were determined by ancova at the 5% level of significance.

      Results

      The change in IELT (1.6 ± 6.08 vs. 0.6 ± 2.07 minutes) and VTS‐ELT (2.9 ± 0.4 vs. 2.4 ± 0.4 minutes) were higher after taking sildenafil, compared with placebo, but did not reach statistical significance. However, patients who took sildenafil (vs. placebo) reported significantly (P < 0.05) increased ejaculatory control (1.8 ± 0.3 vs. 1.5 ± 0.3), increased ejaculatory confidence (2.2 ± 0.2 vs. 1.9 ± 0.2), and improved overall sexual satisfaction scores (3.1 ± 0.2 vs. 2.8 ± 02) on the IPE, and had a decreased postejaculatory erectile refractory time (3.2 ± 0.7 vs. 6.4 ± 0.7 minutes). The most common adverse events for sildenafil (vs. placebo) were headache (15% vs. 1%), flushing (15% vs. 0%), dyspepsia (5% vs. 1%), abnormal vision (5% vs. 0%), and rhinitis (5% vs. 0%).

      Conclusions

      Although IELT and VTS‐ELT were not significantly improved, sildenafil increased confidence, the perception of ejaculatory control, and overall sexual satisfaction, and decreased the refractory time to achieve a second erection after ejaculation in men with PE.

      Keywords

      To read this article in full you will need to make a payment
      ISSM Member Login
      Login with your ISSM username and password.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Spector I.P.
        • Carey M.P.
        Incidence and prevalence of the sexual dysfunctions: A critical review of the empirical literature.
        Arch Sex Behav. 1990; 19: 389-408
        • Dunn K.M.
        • Croft P.R.
        • Hackett G.I.
        Sexual problems: A study of the prevalence and need for health care in the general population.
        Fam Pract. 1998; 15: 519-524
        • American Psychiatric Association.
        Diagnostic and statistical manual of mental disorders..
        American Psychiatric Association;, 1994
        • Laumann E.O.
        • Paik A.
        • Rosen R.C.
        Sexual dysfunction in the United States: Prevalence and predictors.
        JAMA. 1999; 281: 537-544
        • Carson C.C.
        • Glasser D.B.
        • Laumann E.O.
        • West S.L.
        • Rosen R.C.
        Prevalence of premature ejaculation among men aged 40.
        American Urological Association;, 2003
        • Read S.
        • King M.
        • Watson J.
        Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner.
        J Public Health Med. 1997; 19: 387-391
        • Symonds T.
        • Roblin D.
        • Hart K.
        • Althof S.
        How does premature ejaculation impact a man's life?.
        J Sex Marital Ther. 2003; 29: 361-370
        • McCabe M.P.
        Intimacy and quality of life among sexually dysfunctional men and women.
        J Sex Marital Ther. 1997; 23: 276-290
        • O'Leary M.
        Managing early ejaculation: What does the future hold?.
        Rev Urol. 2004; 6: 5-10
        • Waldinger M.D.
        • Zwinderman A.H.
        • Schweitzer D.H.
        • Olivier B.
        Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta‐analysis.
        Int J Impot Res. 2004; 16: 369-381
        • Carson C.C.
        Sildenafil: A 4‐year update in the treatment of 20 million erectile dysfunction patients.
        Curr Urol Rep. 2003; 4: 488-496
        • Melis M.R.
        • Argiolas A.
        Nitric oxide synthase inhibitors prevent apomorphine‐ and oxytocin‐induced penile erection and yawning in male rats.
        Brain Res Bull. 1993; 32: 71-74
        • Melis M.R.
        • Stancampiano R.
        • Argiolas A.
        Nitric oxide synthase inhibitors prevent N‐methyl‐D‐aspartic acid‐induced penile erection and yawning in male rats.
        Neurosci Lett. 1994; 179: 9-12
        • Sato Y.
        • Horita H.
        • Kurohata T.
        • Adachi H.
        • Tsukamoto T.
        Effect of the nitric oxide level in the medial preoptic area on male copulatory behavior in rats.
        Am J Physiol. 1998; 274: 243-247
        • Lorrain D.S.
        • Matuszewich L.
        • Du Howard R.V.J.
        • Hull E.M.
        Nitric oxide promotes medial preoptic dopamine release during male rat copulation.
        Neuroreport. 1996; 8: 31-34
        • Kriegsfeld L.J.
        • Demas G.E.
        • Huang P.L.
        • Burnett A.L.
        • Nelson R.J.
        Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS‐/‐).
        Physiol Behav. 1999; 67: 561-566
        • Machtens S.
        • Ckert S.
        • Stief C.G.
        • Tsikas D.
        • Frlich J.C.
        • Jonas U.
        Effects of various nitric oxide‐donating drugs on adrenergic tension of human seminal vesicles in vitro.
        Urology. 2003; 61: 479-483
        • Heuer O.
        • Uckert S.
        • Machtens S.A.
        • Stief C.G.
        • Tsikas D.
        • Frolich J.C.
        • Jonas U.
        Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro.
        Urology. 2002; 59: 958-962
        • Pinto R.
        • Mota‐Filipe H.
        • Lima B.S.
        Nitric oxide synthase/guanylate cyclase pathway modulates the rat vas deferens contractility induced by phenylephrine.
        Pharmacol Toxicol. 2002; 91: 179-184
        • Pinto R.
        • Barrento C.
        • Mota‐Filipe H.
        • Lima B.S.
        Phenylephrine induces endogenous noradrenaline release in the rat vas deferens through nitric oxide synthase pathway.
        Pharmacol Toxicol. 2003; 93: 191-196
        • Hull E.M.
        • Lumley L.A.
        • Matuszewich L.
        • Dominguez J.
        • Moses J.
        • Lorrain D.S.
        The roles of nitric oxide in sexual function of male rats.
        Neuropharmacology. 1994; 33: 1499-1504
        • Abdel‐Hamid I.A.
        • El Naggar E.A.
        • El Gilany A.H.
        Assessment of as needed use of pharmacotherapy and the pause‐squeeze technique in premature ejaculation.
        Int J Impot Res. 2001; 13: 41-45
        • Chen J.
        • Mabjeesh N.J.
        • Matzkin H.
        • Greenstein A.
        Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation.
        Urology. 2003; 61: 197-200
        • Salonia A.
        • Maga T.
        • Colombo R.
        • Scattoni V.
        • Briganti A.
        • Cestari A.
        • Guazzoni G.
        • Rigatti P.
        • Montorsi F.
        A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation.
        J Urol. 2002; 168: 2486-2489
        • Cappelleri J.C.
        • Rosen R.C.
        • Smith M.D.
        • Mishra A.
        • Osterloh I.H.
        Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function.
        Urology. 1999; 54: 346-351
        • Armitage P.
        • Berry G.
        Statistical methods in medical research..
        3rd edition. Blackwell Scientific Publications;, 1994
        • Tajuddin
        • Ahmad S.
        • Latif A.
        • Qasmi I.A.
        Effect of 50% ethanolic extract of Syzygium aromaticum (L.) Merr. & Perry. (clove) on sexual behaviour of normal male rats.
        BMC Complement Altern Med. 2004; 4: 17.
        • Giuliani D.
        • Ottani A.
        • Ferrari F.
        Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect?.
        Neuropharmacology. 2002; 42: 562-567
        • Mondaini N.
        • Ponchietti R.
        • Muir G.H.
        • Montorsi F.
        • Di Loro F.
        • Lombardi G.
        • Rizzo M.
        Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time.
        Int J Impot Res. 2003; 15: 225-228
        • Aversa A.
        • Mazzilli F.
        • Rossi T.
        • Delfino M.
        • Isidori A.M.
        • Fabbri A.
        Effects of sildenafil (Viagra) administration on seminal parameters and post‐ejaculatory refractory time in normal males.
        Hum Reprod. 2000; 15: 131-134
        • Spiess W.F.
        • Geer J.H.
        • O'Donohue W.T.
        Premature ejaculation: Investigation of factors in ejaculatory latency.
        J Abnorm Psychol. 1984; 93: 242-245
        • Strassberg D.S.
        • Kelly M.P.
        • Carroll C.
        • Kircher J.C.
        The psychophysiological nature of premature ejaculation.
        Arch Sex Behav. 1987; 16: 327-336
        • Kockott G.
        • Feil W.
        • Revenstorf D.
        • Aldenhoff J.
        • Besinger U.
        Symptomatology and psychological aspects of male sexual inadequacy: Results of an experimental study.
        Arch Sex Behav. 1980; 9: 457-475
        • Fugl‐Meyer A.R.
        • Lodnert G.
        • Branholm I.B.
        • Fugl‐Meyer K.S.
        On life satisfaction in male erectile dysfunction.
        Int J Impot Res. 1997; 9: 141-148
        • Latini D.M.
        • Penson D.F.
        • Lubeck D.P.
        • Wallace K.L.
        • Henning J.M.
        • Lue T.F.
        Longitudinal differences in disease specific quality of life in men with erectile dysfunction: Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study.
        J Urol. 2003; 169: 1437-1442
        • Althof S.E.
        • Cappelleri J.C.
        • Shpilsky A.
        • Stecher V.
        • Diuguid C.
        • Sweeney M.
        • Duttagupta S.
        Treatment responsiveness of the Self‐Esteem and Relationship questionnaire in erectile dysfunction.
        Urology. 2003; 61: 888-892
        • McMahon C.G.
        • Abdo C.
        • Incrocci L.
        • Perelman M.
        • Rowland D.
        • Waldinger M.
        • Xin Z.C.
        Disorders of orgasm and ejaculation in men.
        J Sex Med. 2004; 1: 58-65